• (R)-MG132: The Gold Standard Negative Control for Proteasome

  2026-08-03

  (R)-MG132 offers rigorous, stereochemically precise negative controls for proteasome inhibition studies, eliminating ambiguity in mechanistic research. Its functionally inactive profile enables researchers to pinpoint true proteasome-dependent effects and build robust experimental workflows.

• p-Cresyl Sulfate Drives Valvular Calcification via Klotho/SI

  2026-08-03

  This study demonstrates that p-cresyl sulfate, a protein-bound uremic toxin, directly accelerates calcification of aortic valvular interstitial cells by disrupting klotho and sirtuin-1 signaling. These findings clarify a mechanistic link between uremic toxin accumulation and heightened cardiovascular risk in chronic kidney disease, informing future strategies for biomarker-driven research and targeted intervention.

• CH 223191: Benchmark Aryl Hydrocarbon Receptor Antagonist

  2026-08-02

  CH 223191 is a potent, nanomolar aryl hydrocarbon receptor antagonist that enables precise dissection of AhR signaling and dioxin toxicity mechanisms. It reliably inhibits cytochrome P450 1A1 induction and mitigates toxic effects in vitro and in vivo, making it a gold-standard tool for environmental toxicology research.

• Improving In Vitro Assessment of PARP Inhibitors in Cancer M

  2026-08-01

  Schwartz's dissertation critically advances in vitro drug response evaluation by distinguishing between proliferative arrest and cell death metrics, revealing that most cancer drugs—including novel PARP inhibitors—exert effects through both pathways but in varying proportions and timing. These insights refine experimental protocols in cancer pharmacology, supporting more precise analysis of agents like AZD2461 in breast cancer research.

• Butyrate Induces Ferroptosis to Reduce Lung Cancer Stemness

  2026-07-31

  This study demonstrates that butyrate can attenuate the stemness of lung cancer stem cells through a mechanism dependent on lysosomal iron (Fe2+) and SLC7A11-mediated ferroptosis. The findings highlight a novel approach for targeting cancer stem cells by leveraging metabolic regulation and iron homeostasis, offering new avenues for cancer therapy research.

• Atorvastatin in Research: HMG-CoA Reductase Inhibitor Workfl

  2026-07-31

  Atorvastatin, a benchmark HMG-CoA reductase inhibitor, is redefining cholesterol metabolism and vascular biology research while opening new avenues in cancer therapeutics through ferroptosis modulation. This guide delivers advanced workflow strategies, troubleshooting insights, and evidence-based protocol enhancements for translational scientists leveraging APExBIO's trusted Atorvastatin.

• D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Assay

  2026-07-30

  D-Luciferin sodium salt empowers non-invasive, ATP-dependent bioluminescence assays with unmatched sensitivity and reproducibility. From CAR macrophage immunotherapy to metabolic imaging, its high solubility and purity underpin rigorous experimental workflows and troubleshooting strategies for advanced oncology and cell biology research.

• Tacalcitol Monohydrate: Synthetic Analog of Vitamin D3 in Re

  2026-07-30

  Tacalcitol monohydrate, a potent synthetic analog of vitamin D3, empowers researchers to modulate keratinocyte behavior, induce nerve growth factor, and enhance anticancer regimens with precision and low toxicity. Its validated workflows bridge dermatology and oncology, offering reproducible, protocol-driven results for advanced cell biology applications.

• Z-LEHD-FMK: Advancing Translational Apoptosis Research

  2026-07-29

  Explore how the irreversible caspase-9 inhibitor Z-LEHD-FMK is reshaping translational research in apoptosis, from mechanistic insight to neuroprotection and cancer models. This article bridges foundational knowledge, recent advances—including SARS-CoV-2 apoptosis findings—and strategic guidance for leveraging Z-LEHD-FMK in next-generation experimental designs.

• Z-YVAD-FMK: Precision Caspase-1 Inhibition in Pyroptosis Ass

  2026-07-29

  Explore how Z-YVAD-FMK, a potent caspase-1 inhibitor, enables advanced apoptosis and pyroptosis research. This article provides a deep scientific analysis and practical guidance, grounded in recent discoveries and unique assay considerations.

• Promethazine HCl in Macrophage Immunometabolism Research

  2026-07-28

  Promethazine HCl is redefining the landscape of host-directed antibacterial research by leveraging macrophage immunometabolism and histaminergic pathway inhibition. This article offers stepwise experimental guidance, troubleshooting insights, and strategic perspective on deploying Promethazine HCl in inflammation and neuroscience applications.

• Metformin HCl: Mechanistic Pathways to Translational Breakth

  2026-07-28

  This article examines the mechanistic intricacies and translational potential of Metformin Hydrochloride (Metformin HCl), with a focus on AMPK signaling and its implications for fibrotic disorders. Drawing on recent preclinical evidence, including a landmark study on vocal fold fibrosis, we guide researchers through strategic experimental design, highlight differentiation from standard guides, and provide actionable parameters for translational research using APExBIO's Metformin HCl.

• Inhaled RNA Nanotherapy Remodels Lung Tumor Collagen for Imm

  2026-07-27

  This study introduces an inhalable lipid nanoparticle system that delivers mRNA encoding anti-DDR1 antibody fragments and siRNA targeting PD-L1 to lung tumors. By disrupting collagen fiber alignment and immune suppression, the approach enhances T cell infiltration and antitumor efficacy, representing a significant advance in RNA-based cancer immunotherapy.

• EZ Cap™ Human PTEN mRNA: Next-Gen Platforms for Precision Tu

  2026-07-27

  Explore how EZ Cap™ Human PTEN mRNA empowers precision tumor suppressor gene mRNA strategies in cancer research. This article uniquely dissects the intersection of advanced mRNA engineering and targeted delivery, offering new perspectives on translational applications and assay decisions.

• Decoding EZ Cap Cy5 Firefly Luciferase mRNA: Tracking, Trans

  2026-07-26

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables precise mRNA delivery, intracellular tracking, and translation efficiency. This article uniquely connects advanced design features with practical assay optimization, integrating recent findings on colloidal stability for next-generation applications.

15828 records 1/1056 page Next 12345 下5页 Last page